Harrow, Inc.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Harrow, Inc. 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About HROW

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. 

CEO
Mark L. Baum
CEOMark L. Baum
Employees
373
Employees373
Headquarters
Nashville, Tennessee
HeadquartersNashville, Tennessee
Founded
2006
Founded2006
Employees
373
Employees373

HROW Key Statistics

Market cap
1.31B
Market cap1.31B
Price-Earnings ratio
-215.29
Price-Earnings ratio-215.29
Dividend yield
—
Dividend yield—
Average volume
762.83K
Average volume762.83K
High today
$35.84
High today$35.84
Low today
$33.60
Low today$33.60
Open price
$33.77
Open price$33.77
Volume
511.60K
Volume511.60K
52 Week high
$54.85
52 Week high$54.85
52 Week low
$20.85
52 Week low$20.85

Stock Snapshot

As of today, Harrow, Inc.(HROW) shares are valued at $35.84. The company's market cap stands at 1.31B, with a P/E ratio of -215.29.

On 2026-03-25, Harrow, Inc.(HROW) stock traded between a low of $33.60 and a high of $35.84. Shares are currently priced at $35.84, which is +6.7% above the low and 0.0% below the high.

The Harrow, Inc.(HROW)'s current trading volume is 511.6K, compared to an average daily volume of 762.83K.

During the past year, Harrow, Inc.(HROW) stock moved between $20.85 at its lowest and $54.85 at its peak.

During the past year, Harrow, Inc.(HROW) stock moved between $20.85 at its lowest and $54.85 at its peak.

HROW News

TipRanks 12h
Harrow Health Prices $50 Million Senior Notes Offering

Harrow Health ( (HROW) ) just unveiled an announcement. On March 24, 2026, Harrow announced it had priced a $50 million private offering of 8.625% senior unsec...

Nasdaq 20h
A Major Investor Just Sold $7.8 Million in Harrow Stock -- Is This a Sell Signal?

Key Points Opaleye Management Inc. disposed of 198,572 shares indirectly across two days, with a transaction value of roughly $7.8 million based on weighted av...

A Major Investor Just Sold $7.8 Million in Harrow Stock -- Is This a Sell Signal?
TipRanks 6d
Harrow Health: Evolving Into an Integrated Ophthalmic Platform With Clinical Catalysts and Commercial Upside Supporting a Buy Rating

Analyst Thomas Shrader of BTIG maintained a Buy rating on Harrow Health, retaining the price target of $63.00. Claim 70% Off TipRanks Premium Unlock hedge fund-...

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own HROW. This list is generated using Robinhood data, and it’s not a recommendation.
Nebius Group
Rocket Lab Corporation
IREN Limited
Hims & Hers Health
Robinhood Markets
Ondas Inc.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.